CDIOCardio Diagnostics Holdings, Inc.vs its industry peers
A metric-by-metric comparison of Cardio Diagnostics Holdings, Inc. against In Vitro & In Vivo Diagnostic Substances — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CDIOThis | $6M#10 | — | 0.8x#4 | 405.2x#11 | -57.5%#11 | 22.5%#7 | -43737.5%#11 | -87.5%#5 | — | — | -46.3%#6 | — |
| QDEL | $738M#2 | — | 0.4x#2 | 0.3x#1 | -1.9%#8 | 44.8%#4 | -33.7%#2 | -63.8%#3 | -19.5%#1 | — | -63.6%#9 | — |
| TKNO | $383M#3 | — | 6.1x#7 | 9.4x#7 | 7.4%#4 | 35.5%#5 | -41.9%#4 | -27.6%#2 | -25.2%#2 | 5#1 | 58.1%#2 | — |
| MYGN | $367M#4 | — | 1.2x#5 | 0.4x#2 | -1.6%#7 | -188.2%#14 | -47.0%#5 | -120.4%#7 | -76.1%#4 | — | -48.7%#7 | — |
| IMDX | $116M#6 | — | — | 28.6x#9 | 115.6%#1 | 17.2%#9 | -1260.8%#10 | — | — | — | 2.6%#3 | — |
| ICCC | $87M#7 | — | — | — | — | — | — | — | — | — | 65.5%#1 | — |
| QCLS | $8M#9 | 0.0x#1 | 0.5x#3 | 5.0x#6 | -5.3%#9 | 50.2%#2 | -624.4%#8 | -72.3%#4 | -61.2%#3 | — | -75.6%#11 | — |
| BMRA | $11M#8 | — | 4.1x#6 | 2.4x#4 | -16.2%#10 | 24.1%#6 | -119.5%#7 | -143.5%#8 | — | — | -22.0%#5 | — |
| VNRX | $4M#11 | — | — | 2.2x#3 | 40.0%#2 | 13.4%#10 | -1258.5%#9 | — | — | — | -97.8%#13 | — |
| CDIOW | $40249#12 | — | 0.0x#1 | 2.7x#5 | -57.5%#11 | 22.5%#7 | -43737.5%#11 | -87.5%#5 | — | — | -0.7%#4 | — |
| AWHL | — | — | — | — | 0.4%#6 | 2.4%#11 | -85.9%#6 | — | — | 3#2 | — | — |
| BZYR | — | — | — | — | — | -3.8%#12 | — | — | — | — | — | — |
| NNNN | $241M#5 | 37.6x#2 | 8.0x#8 | 27.9x#8 | 5.6%#5 | 169.9%#1 | 66.7%#1 | 21.2%#1 | — | — | -87.1%#12 | — |
| NYMXF | — | — | — | — | — | 49.2%#3 | — | — | — | — | -49.6%#8 | — |
| TRIB | $4.5B#1 | — | — | 73.4x#10 | 8.3%#3 | -32.4%#13 | -34.4%#3 | — | — | — | -66.7%#10 | 0.1%#1 |
Peer set: US filers sharing this company's SEC industry classification (SIC 2835). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Table built 2026-09-17.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice